Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 77 results found. Search for [ Lupin share price ]

Results 1 to 21 of 77
BusinessToday.In
February 11, 2019
The Dr Reddy's Laboratories share opened at a loss of 3.69% at 2,670 today compared to the previous close of 2,772.30 on the BSE. The Dr Reddy's Laboratories stock further crashed 216 points or 7.81% to 2555.5 level on the BSE.


BusinessToday.In
February 7, 2019
The Lupin earnings came below street expectations. The Mumbai-based firm reported a net profit of Rs 221.73 crore in the October-December period of previous fiscal. The Lupin share price fell 3.68% to 811 level intra day compared to the previous close of 841.95 on the BSE.


PB Jayakumar
New Delhi, November 26, 2018
Market changes and increased regulatory oversight in the US have hurt Lupin, but India's third-biggest drug maker is making efforts to come back.


E Kumar Sharma
New Delhi, November 21, 2018
Some of the leading Indian pharma companies are pitching in to cater to the markets that some of the big pharma companies are vacating as part of their product optimisation strategies.


PB Jayakumar
New Delhi, October 29, 2018
A big transformation is happening in the global generic pharmaceutical industry. As a result, stocks of most major drug companies have done badly in the past one year.


BusinessToday.in
New Delhi, October 4, 2018
Rakesh Jhunjhunwala has notched up big notional losses in portfolio stocks, especially in the midcaps space.


BusinessToday.In
New Delhi, September 13, 2018
India reportedly boasts around 2,000 FDCs, four times more that what's available in the US.


Nevin John
New Delhi, August 29, 2018
Reports say that both JSW and Tata look to submit bids for Usha Martin's 1 MT steel unit.


PTI
May 16, 2018



P.B. Jayakumar
New Delhi, April 30, 2018
Drug companies are moving up the value chain, transforming into complex generic manufacturers with high end R&D facilities.


Kundan Kishore
New Delhi, April 2, 2018
Stock prices can sometimes fall like a brick, but that does not mean you can bottom-fish. Here's how you can avoid a costly plunge.


Kundan Kishore
New Delhi, March 5, 2018
Have markets become more volatile or are they witnessing a minor correction that will bring the stocks down to comfortable valuation levels?


BusinessToday.in
February 6, 2018
It took 29 days for the Sensex to climb up nearly 2,500 points last month, hitting a peak of close to 36284 on January 29. But it took just eight days to lose this hard-won ground, eroding investors' wealth by over Rs 6 lakh crore along the way.


E. Kumar Sharma
New Delhi, January 10, 2018
By following the strategy of doing a few things well, V.C. Nannapaneni has helped Natco Pharma carve out a space for itself.


E Kumar Sharma
New Delhi, January 4, 2018
The only writing on the wall for Indian pharma companies is to chase complex and high-end products.


E Kumar Sharma
New Delhi, December 28, 2017
 The just concluded year, hurt Indian pharma companies in more ways than one


P.B. Jayakumar
New Delhi, December 11, 2017
Margin erosion and regulatory hurdles are hitting Indian pharma companies hard in their biggest market.


E. Kumar Sharma
New Delhi, November 25, 2017
Pharma stocks continue to underperform as policy uncertainty adds to the toll taken by USFDA and market challenges.


BT Online
November 14, 2017
Tata Global Beverages September-quarter group consolidated net profit at Rs 144 crore versus profit of Rs 127 crore last year. Eicher Motors Q2 consolidated net profit at Rs 518 crore versus profit of Rs 413 crore last year. Shares slip 1.67 percent to 30,050 level.


E Kumar Sharma
New Delhi, November 7, 2017
Just last month when Lupin announced an acquisition in the US in a niche therapy area, analysts pointed out that the company may have to wait for a couple of years more for benefits to accrue.


PAGES 1 OF 4  1234